In July, the Department of Health and Social Care (DHSC) and Britain's National Health Service declared a national shortage of Ozempic and all other drugs in a class called "GLP-1 receptor agonists" due to the soaring demand for approved and off-label use.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/QGVocCd
via gqrds
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment